All the Active Ingredient Drugs
Pyrimidine Analogues. Gemcitabine (HCl) 4 mg/ml. VIAL (conc. for sol. for infus.): 1 x 200 mg
x 40 mg/ml; 1 x 1,000 mg x 40 mg/ml.
I.V. Adjust. accord. indicats, gen. cond.,
hepat./ren. funct., concur. chemother.,
bl. counts. See lit.
Pall. tmt in local. advanced/ metastat.
NSCLC, local. advanced/metastat.
adenocarcinoma pancreas, 5-FU refract.
pancreat. cancer, bladder cancer at invas.
stage. In combinat. with paclitaxel for tmt
pts. with unresect. local. recur./metastat.
breast cancer who have relapsed follow.
adjuv./neoadjuv. chemother. Prior
chemother. should have included
anthracycline unless C/I. In comb. with
carboplatin for recur. epithelial ovarian
carcinoma that has relapsed at least 6
mths aft. platinum based ther.
C/I: Hypersens., pregn., lact. See lit.
Pyrimidine Analogues. Gemcitabine (as HCl) 40 mg/ml. VIALS (concentrate for sol. for infus.) of 5,
25, 50 ml x 1. Dosage must be individ. adjust. for each pt. accord. to the medical condit. Not to be used in children under 18
years of age.
Palliative tmt. of adult pts. with local.
advance.,metast. non-small cell lung can.,
local. advance., metast. adenocarcin. of
the pancr., pts. with 5-FU refract. panc.can.
Tmt. of pts. with bladder can. at the invas.
stage.
Breast can.: In comb. with paclitaxel, for
the tmt. of pts. with unresect. local.recur.,
metast. breast can. who have relapsed
follow. adjuvant/neoadjuv. chemother.
Prior chemother. should have include. an
anthracycline unless clinic.contraind.
Ovar. can.: In comb.with carboplatin; tmt.
of pts. with recur. epith. ovar. carcin. who
have relapsed at least 6 mts. after
platinum-based ther.
C/I: Hypersens. lact.
Antimetabolite (pyrimidine analog). Gemcitabine (HCl) 200 mg. VIALS: 1 x 200 mg. 1,000 mg/m².
See lit.
NSCLC, pancreat. cancer, bladder
cancer at invasive stage. In com. with
paclitaxel in unresect. local. recur. or metastat. Breast cancer who have
relapsed foll. adjuvant/ neoadjuvant
chemother. Prior chemother. should
have included an anthracycline unless
clin. contraindicat. in comb. With
carboplatin for tmt pts. with recur.
epithel. ovarian carcinoma who have
relapsed at least 6 mths aft. platinumbased
ther. Therapeut. activity:
Advanced or relapse.
epithel. ovarian cancer alone/in comb.
with other chemother. agents.
C/I: live attenuated vaccines, see lit.
